Sign in

CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company

BICYCLE THERAPEUTICS PLC

Sign in to watch
Ticker
BCYC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
011441223261503
Business address
BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
Former names
BICYCLE THERAPEUTICS Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$64,039
in 7 filings, $7K under 10b5-1 plans

Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
  2. Swanton Robert Charles −$12K Director sold 18% of stake
  3. Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
  4. Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
  5. Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
Date Insider Transaction Shares Price Value Owned after
2019-05-28 Vertex Global Healthcare Fund I Pte Ltd. 10% owner Conversion +206,767 1,621,168
2019-05-28 Vertex Global Healthcare Fund I Pte Ltd. 10% owner Conversion · Series B1 Preferred Shares −1,272,733 0
2019-05-28 Vertex Global Healthcare Fund I Pte Ltd. 10% owner Option exercise · Series B1 Preferred Shares Warrants −141,668 0
2019-05-28 Vertex Global Healthcare Fund I Pte Ltd. 10% owner Conversion · Series B2 Preferred Shares −206,767 0
2019-05-28 Novartis Bioventures Ltd 10% owner Conversion +893,195 893,195
2019-05-28 Novartis Bioventures Ltd 10% owner Option exercise +71,450 964,645
2019-05-28 Novartis Bioventures Ltd 10% owner Conversion +636,366 1,601,011
2019-05-28 Novartis Bioventures Ltd 10% owner Purchase +168,630 $14.00 $2.4M 1,769,641
2019-05-28 Novartis Bioventures Ltd 10% owner Conversion · Series A Preferred Shares −893,195 0
2019-05-28 Novartis Bioventures Ltd 10% owner Option exercise · Series A Preferred Shares Warrants −71,450 0
2019-05-28 Novartis Bioventures Ltd 10% owner Conversion · Series B1 Preferred Shares −636,366 0
2019-05-28 Winter Gregory Paul Director Conversion +42,870 92,477
2019-05-28 Winter Gregory Paul Director Conversion · Series A Preferred Shares −42,870 0
2019-05-28 NG CAROLYN Director Conversion +1,272,733 1,272,733
2019-05-28 NG CAROLYN Director Option exercise +141,668 1,414,401
2019-05-28 NG CAROLYN Director Conversion +206,767 1,621,168
2019-05-28 NG CAROLYN Director Conversion · Series B1 Preferred Shares −1,272,733 0
2019-05-28 NG CAROLYN Director Option exercise · Series B1 Preferred Shares Warrants −141,668 0
2019-05-28 NG CAROLYN Director Conversion · Series B2 Preferred Shares −206,767 0
2019-05-28 SVLSF V, LLC 10% owner Conversion +874,709 874,709

Page 31 of 34 · 664 trades